TipRanks
Go Ultimate55% OFF

BioMarin Pharmaceutical (BMRN) Balance Sheet

BioMarin Pharmaceutical Balance Sheet

BioMarin Pharmaceutical's total assets for Q2 2026 were $11.72B, an increase of 36.46% from the previous quarter. MX:BMRN total liabilities were $5.40B for the fiscal quarter, a 127.07% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 7.59B$ 6.99B$ 6.84B$ 6.38B$ 6.00B
$ 1.51B$ 1.33B$ 1.89B$ 1.77B$ 1.74B
$ 6.09B$ 5.66B$ 4.95B$ 4.60B$ 4.27B

Currency in USD

BioMarin Pharmaceutical Debt to Assets

03B6B9B12 %24 %36 %48 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets